Teligent Current Ratio 2010-2021 | TLGT
Teligent current ratio from 2010 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Teligent Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2021-06-30 |
$0.05B |
$0.01B |
4.10 |
2021-03-31 |
$0.06B |
$0.01B |
4.39 |
2020-12-31 |
$0.04B |
$0.02B |
1.92 |
2020-09-30 |
$0.05B |
$0.02B |
2.48 |
2020-06-30 |
$0.05B |
$0.02B |
2.27 |
2020-03-31 |
$0.05B |
$0.02B |
2.86 |
2019-12-31 |
$0.06B |
$0.02B |
3.71 |
2019-09-30 |
$0.05B |
$0.04B |
1.48 |
2019-06-30 |
$0.05B |
$0.03B |
1.61 |
2019-03-31 |
$0.05B |
$0.03B |
1.46 |
2018-12-31 |
$0.05B |
$0.03B |
1.48 |
2018-09-30 |
$0.05B |
$0.04B |
1.32 |
2018-06-30 |
$0.05B |
$0.02B |
2.75 |
2018-03-31 |
$0.05B |
$0.02B |
2.73 |
2017-12-31 |
$0.06B |
$0.02B |
3.16 |
2017-09-30 |
$0.08B |
$0.03B |
3.16 |
2017-06-30 |
$0.10B |
$0.02B |
4.37 |
2017-03-31 |
$0.10B |
$0.02B |
5.62 |
2016-12-31 |
$0.10B |
$0.02B |
6.90 |
2016-09-30 |
$0.11B |
$0.01B |
8.48 |
2016-06-30 |
$0.11B |
$0.01B |
8.60 |
2016-03-31 |
$0.12B |
$0.01B |
9.08 |
2015-12-31 |
$0.12B |
$0.01B |
10.85 |
2015-09-30 |
$0.16B |
$0.01B |
17.78 |
2015-06-30 |
$0.17B |
$0.01B |
13.11 |
2015-03-31 |
$0.18B |
$0.02B |
11.66 |
2014-12-31 |
$0.18B |
$0.01B |
13.63 |
2014-09-30 |
$0.03B |
$0.01B |
2.90 |
2014-06-30 |
$0.01B |
$0.01B |
2.28 |
2014-03-31 |
$0.01B |
$0.00B |
2.66 |
2013-12-31 |
$0.01B |
$0.01B |
2.02 |
2013-09-30 |
$0.01B |
$0.00B |
2.50 |
2013-06-30 |
$0.01B |
$0.00B |
2.31 |
2013-03-31 |
$0.01B |
$0.00B |
2.52 |
2012-12-31 |
$0.01B |
$0.00B |
3.11 |
2012-09-30 |
$0.00B |
$0.00B |
3.16 |
2012-06-30 |
$0.01B |
$0.00B |
3.17 |
2012-03-31 |
$0.01B |
$0.00B |
3.22 |
2011-12-31 |
$0.01B |
$0.00B |
4.32 |
2011-09-30 |
$0.01B |
$0.00B |
6.05 |
2011-06-30 |
$0.01B |
$0.00B |
7.08 |
2011-03-31 |
$0.01B |
$0.00B |
6.90 |
2010-12-31 |
$0.01B |
$0.00B |
7.91 |
2010-09-30 |
$0.00B |
$0.00B |
1.97 |
2010-06-30 |
$0.00B |
$0.00B |
2.25 |
2010-03-31 |
$0.00B |
$0.00B |
2.67 |
2009-12-31 |
$0.00B |
$0.00B |
2.74 |
2009-09-30 |
$0.00B |
$0.00B |
3.38 |
2009-06-30 |
$0.01B |
$0.00B |
3.56 |
2009-03-31 |
$0.01B |
$0.01B |
1.05 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|